trending Market Intelligence /marketintelligence/en/news-insights/trending/JkaBgHD80Qq8UePgFzACOQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

FDA allows Swedish Match to market smokeless tobacco products as 'less harmful'

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

FDA allows Swedish Match to market smokeless tobacco products as 'less harmful'

The U.S. Food and Drug Administration has authorized Swedish Match AB's U.S. arm to market its snus smokeless tobacco products as less harmful to consumers, according to an Oct. 22 release.

The agency said it has concluded that completely switching from cigarettes to Swedish Match USA Inc.'s products lowers certain health risks. It has therefore allowed the company to sell the items through the modified risk tobacco product pathway.

The authorization is limited to five years and covers eight of the company's snus smokeless tobacco products sold under the General brand name. Swedish Match USA can market the products with the claim "Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis."

The FDA noted that the move does not mean these products are safe or "FDA approved," adding that all tobacco products are potentially harmful and addictive.

"Today's action demonstrates the viability of the pathway for companies to market specific tobacco products as less harmful to consumers, but only following a thorough scientific evaluation by the FDA," the agency said.

The decision comes as the agency, along with other government institutions, ramps up the crackdown on vaping products and e-cigarettes following reports that these products cause seizures and respiratory illnesses. The multi-agency campaign against vaping has targeted companies like Juul Labs Inc., its shareholder Altria Group Inc. and Altria subsidiary Philip Morris USA Inc.

Earlier in October, the FDA warned customers not to use vaping products containing THC after the U.S. Centers for Disease Control and Prevention registered 1,080 lung injury cases related to vaping, with 18 confirmed deaths. As of Oct. 15, the death toll has risen to 33 and the number of injuries has grown to 1,479.